ISoP is pleased to announce Vijay Ivaturi, Ph.D., as the 2023 President-Elect. Dr. Ivaturi will serve in this role for a one-year term and then will assume the ISoP presidency in January 2024, for a two-year term. As President-Elect, Dr. Ivaturi will oversee the development of ISoP’s three-year strategic plan to advance ISoP’s mission for the promotion and advancement of the discipline of pharmacometrics. “Dr. Ivaturi has contributed to advancing our society’s initiatives and the field of pharmacometrics for many years, said Cynthia (CJ) Musante, ISoP President. I look forward to his continued leadership as ISoP transitions to a 501(c)(3) non-profit organization and we advance our shared vision for the society.”
“It is an honor to serve as the next President-elect of ISoP. Volunteering and being part of ISoP has been a highlight of my career for the last 14 years since ACoP 2008, said Dr. Ivaturi, Co-Founder and Chief Scientific Officer (CSO) of Pumas-AI. I look forward to working with the membership and our partners to promote and democratize the field of pharmacometrics globally. I am especially excited about expanding our efforts internationally, promoting diversity and inclusion across all facets of our community, welcome emerging areas of pharmacometrics, such as model-informed drug development, model-informed precision dosing and machine learning.”